All posts by imreal

Fenway Health joins AMAF consortium of institutions to address LGBTQ+ health disparities


Fenway Health rectangular blue logo with white lettering

The AMAF is uniquely positioned to serve as a convening force to improve LGBTQ+ health equity by facilitating collaboration and knowledge sharing between key stakeholders and institutional leaders that will transform health care systems to be LGBTQ+ inclusive and affirming.

Harvard Medical School affiliated hospitals, Fenway Health, and Vanderbilt University Medical Center join national fellowship initiative

The American Medical Association Foundation (AMAF) announced today that several of Harvard Medical School (HMS)’s affiliated hospitals in collaboration with Fenway Health in Boston, Mass., and Vanderbilt University Medical Center (VUMC) in Nashville, Tenn., will participate in the AMAF National LGBTQ+ Fellowship Program consortium of institutions. They join the pilot fellowship at Icahn School of Medicine at Mount Sinai in New York City, N.Y., and the 2021 inaugural institution at the University of Wisconsin School of Medicine and Public Health in Madison, Wis. Today’s announcement marks the next chapter in the Foundation’s transformational initiative.

Launched in 2020, the fellowship program aims to provide enhanced physician training, education and cultural sensitivity while bringing awareness to the health care and institutional barriers faced by LGBTQ+ and intersecting communities. The program’s ultimate mission is to ensure that all LGBTQ+ patients receive the highest standards of care while helping to transform the landscape of medical education. The addition of two exceptional teaching institutions to the program demonstrates the AMAF’s commitment to moving the needle and taking the fellowship to scale nationwide.

“The AMAF is uniquely positioned to serve as a convening force to improve LGBTQ+ health equity by facilitating collaboration and knowledge sharing between key stakeholders and institutional leaders that will transform health care systems to be LGBTQ+ inclusive and affirming,” says Dr. William Sternfeld, president of the AMAF Board of Directors. “The result will be a workforce of LGBTQ+ health specialists with a rich body of knowledge that can be shared with all medical schools and health care professionals.”

The AMAF Board of Directors approved the recommendation from the Fellowship Commission on LGBTQ+ Health to award two grants as part of the second cycle of applications in effort to amplify and accelerate the impact of the program. The commission noted several factors in its recommendation to accept the HMS-Fenway and VUMC fellowships into the program, such as the extensive network of clinics across HMS affiliates and Fenway Health that serve LGBTQ+ patients from adolescence through older adulthood. HMS also established the Sexual and Gender Minority Health Equity Initiative to teach students foundational clinical skills in LGBTQIA+ health care while exploring the intersections of anti-LGBTQIA+ stigma with racism, ageism and ableism. The fellowship will extend and deepen this foundational work by implementing LGBTQIA+ health training systemwide for fellows, residents and faculty. HMS-affiliated clinical sites participating in the fellowship include Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, and Massachusetts General Hospital. Boston Children’s Hospital, Cambridge Health Alliance and Mount Auburn Hospital will serve as supplemental clinical elective sites.

“Our multi-site Harvard Medical School-Fenway Health LGBTQIA+ Fellowship team is honored and thrilled to have the opportunity to join the AMAF National LGBTQ+ Fellowship Program. Now more than ever, we need to equip the next generation of physician leaders in LGBTQIA+ health with the skills to provide comprehensive and affirming care for all LGBTQIA+ populations, across the lifecycle, with a focus on serving marginalized LGBTQIA+ communities,” states Jennifer Potter, MD, professor of medicine at Beth Israel Deaconess Medical Center and Harvard Medical School; and director of the LGBTQIA+ Population Health Program and co-chair at The Fenway Institute.

The AMAF Fellowship Commission also recognized VUMC’s commitment to personalized medicine and to improving outcomes for LGBTQ+ patients at VUMC and across the U.S. Established in 2012, VUMC’s Program for LGBTQ+ Health has a 10-year track record of investing in LGBTQ+ health and promoting national leadership in patient care, education, research and advocacy for the LGBTQ+ community. The clinical LGBTQ+ program at VUMC includes the Clinic for Transgender Health that brings together specifically trained experts to provide and coordinate comprehensive care for transgender and gender-nonconforming adults. The fellowship program will intercalate LGBTQ+ health education with all disciplines and throughout curricula at all levels of learners. VUMC’s organizational expertise in data informatics will allow for rapid dissemination of internal and external outcomes.

“We are incredibly excited and grateful to be a part of this consortium, in this group of academic medical centers working together to promote inclusive and personalized care for patients,” says Dr. Kyla Terhune, vice president for Educational Affairs at VUMC.

The fellowship initiative is in response to persistent, pervasive disparities regarding access to and quality of health care experienced regularly by LGBTQ+ individuals. Studies show that 80 percent of medical students demonstrate a bias of LGBTQ+ patients, leading to 1 in 5 LGBTQ+ adults avoiding health care services due to fear of discrimination. The result is not just harmful, it is deadly. The AMAF and participating institutions will address these inequities while building on existing foundations of diversity, equity and inclusion strategies that support affirming LGBTQ+ services. The AMAF welcomes individuals, foundations and corporations to join the conversation and connect with the Foundation to ensure all LGBTQ+ Americans have access to medical care.

Share article on social media or email:

Growing, Aging Population Impacts Healthcare


“Increasing disease prevalence and a growing adoption of Western lifestyle trends will continue to negatively impact healthy life years, while overall life expectancy is increasing, thus placing increased pressure on India’s healthcare resources.”

India, which is expected to surpass China as the most populous country in the world by 2023, has a growing $1,482 million ($1.5 billion) in vitro diagnostics (IVD) industry that is forecast to increase through 2026, as reported by Kalorama Information in the new medical market research study, In Vitro Diagnostics (IVD) in India.

The IVD market in India is considered complex in its regulatory process and has a fragmented system for device registration and geographical market penetration. Despite the challenges, the IVD market is growing at a 2% compound annual growth rate (CAGR) and showing a strong influx in foreign investments. India is highly dependent on medical imports and continues to grow despite the increasing number of domestic medical equipment suppliers.

An overarching trend affecting India’s healthcare system is the expected and continued shift toward aging adults. India already saw an uptick in its age 65+ population between 2017 and 2022. India’s elderly population is expected to rise 20% over the next decade reaching 115 million in 2030 from 95 million in 2020. By 2060, the 65+ population will account for 19% of the total population, up from just 6% in 2010. The age 15-64 population group is expected to remain relatively stable; while the age 0-14 population is declining, and is forecast to account for just 16% of the population in 2060, down from 30% in 2010. This is expected to place an increasing strain on caring for the country’s oldest population.

“A graying population is a trend that is consistent with most other countries of the world, as the distribution of the population is expected to shift toward the 65 and over population. The shift is expected to increase disease incidence overall as older adults are more vulnerable to disease and illness,” says Daniel Granderson, associate editor for Kalorama Information.

The growing rate of cardiovascular disease, diabetes and other non-communicable diseases has and is expected to continue to influence life expectancy in India. There is an expected increase in chronic diseases incidence and morbidity of disease for the years ahead forecast by Kalorama Information.

“Increasing disease prevalence and a growing adoption of Western lifestyle trends will continue to negatively impact healthy life years, while overall life expectancy is increasing, thus placing increased pressure on India’s healthcare resources,” says Granderson.

For more insights like these or to purchase our report, “In Vitro Diagnostics (IVD) in India,” visit: https://kaloramainformation.com/product/in-vitro-diagnostics-ivd-in-india/.

Share article on social media or email:

NCPDP Announces Call for Proposals for its 2023 Annual Technology & Business Conference, “The Great Race to Close Gaps in Care”


News Image

NCPDP announced today the call for proposals for its 2023 Annual Technology & Business Conference, “The Great Race to Close Gaps in Care,” which will be held May 8-10, 2023, at the Westin Kierland Resort & Spa in Scottsdale, Arizona. NCPDP’s national conference draws more than 700 attendees from across the healthcare industry, including technical, business, and executive representatives from health plans, pharmacy benefit managers, retail and independent pharmacies, specialty pharmacies, long-term care providers, healthcare consultants, technology vendors, pharmaceutical manufacturers, wholesale drug distributors, database management organizations and others.

“The Great Race to Close Gaps in Care is more than a theme for our 2023 Annual Conference – it captures our earnest enthusiasm to tackle gaps in care that can potentially affect patients’ health and safety, and the ability to optimize healthcare outcomes,” explained Lee Ann Stember, NCPDP President & CEO. “At the heart of many of our strategic initiatives is the imperative to address interoperability issues such as data access, measurement, and data modernization, to support better quality patient care amongst the care team, inclusive of pharmacists, in and across a variety of care settings. We invite all industry stakeholders to join us in this great race to collaborate on sustainable standards and solutions that address gaps in access, quality, and continuity of care to improve the healthcare experience.”

NCPDP is accepting submissions for two session formats at its 2023 Annual Conference:

  •     Standard Track Sessions are 60-minute sessions, providing for a 45-minute presentation and 15 minutes of question and answer. These sessions are limited to a maximum of two (2) speakers. However, the 2023 Annual Conference Subcommittee will consider more than two speakers/panel discussions if the topic warrants, and the proposal must include a thorough description and detailed information on the session and speakers/panelists (all form fields must be completed).
  •     Rapid-fire, Hot Topic Sessions are 30-minute sessions focused on a high-level overview of an emerging trend. These sessions are designed to be both cutting-edge and highly focused, requiring the presenter to share ideas and achieve learning objectives in 20 minutes, with the remaining 10 minutes open for interactive discussion. These sessions are intended for one speaker, but if the topic warrants, can have a maximum of two (2) speakers.

NCPDP encourages the submission of proposals covering a broad range of educational, informative healthcare and pharmacy topic areas, such as:

  •     Artificial Intelligence
  •     Behavioral Nudges
  •     Blockchain Technology
  •     Care Coordination
  •     Compliance, Accreditation, Government Mandates and Audits, HIPAA
  •     Data and Analytics
  •     Digital Therapeutics, Technology
  •     Emerging Pharmacy Treatments
  •     Emerging Technologies
  •     Food and Drug Administration Programs
  •     Impact of Regulatory/Legislative Environment on NCPDP Standards, Membership, Priorities
  •     Long-term Care, Hospice
  •     Pharmacogenomics
  •     Population Health Management
  •     Precision Medicine
  •     Medicaid and Medicare Programs
  •     Medication Adherence, Medication Management
  •     mHealth (mobile health)
  •     Patient Experience, Patient Engagement
  •     Pharmacist as Provider, Pharmacist Provided Patient Care
  •     Pharmacy Quality Measures
  •     Prior Authorization
  •     Real Time Prescription Benefit
  •     Rebates, Chargebacks
  •     Social Determinants of Health
  •     Specialty Pharmacy
  •     Standards & Interoperability
  •     Telehealth
  •     Value Based Care
  •     Wearables Data

NCPDP encourages presentations that support or tie to the conference theme, wherever possible. Preference will be given to case studies, pilot results and emerging trends. The deadline to submit a proposal is October 4, 2022.

For more information or to submit a proposal, visit: https://ncpdp.org/ac/call-for-proposals-info.aspx.

For real-time updates before and during the conference, follow us at http://twitter.com/ncpdp or join the discussion using NCPDP’s 2023 Annual Technology & Business Conference hashtag: #NCPDP23.

About NCPDP

Founded in 1977, NCPDP is a not-for-profit, ANSI-accredited, Standards Development Organization with more than 1,500 members representing virtually every sector of the pharmacy services industry. Our diverse membership provides leadership and healthcare business solutions through education and standards, created using the consensus building process. NCPDP has been named in federal legislation, including HIPAA, MMA, and HITECH. NCPDP members have created standards such as the Telecommunication Standard and Batch Standard, the SCRIPT Standard for ePrescribing, the Manufacturers Rebate Standard and more to improve communication within the pharmacy industry. Our data products include dataQ®, a robust database of information on more than 80,000 pharmacies, resQ™, an industry pharmacy credentialing resource, and HCIdea®, an innovative prescriber database that provides continually updated information on more than 2.5 million prescribers. NCPDP’s RxReconn® is a legislative tracking product for real-time monitoring of pharmacy-related state and national legislative and regulatory activity. For more information about NCPDP Standards, Data Services, Products, Educational Programs and Work Group meetings, go online at http://www.ncpdp.org or call 480.477.1000.

###

Share article on social media or email:



Dee for Dentist Becomes First Dental Practice in Western U.S. to Utilize First-Ever Medical Grade 3D Printing System for Dentistry


News Image

Dee for Dentist is a state-of-the-art dental practice embracing groundbreaking technological innovations and techniques, including the first-ever medical grade 3D printer for dentistry.

Dee for Dentist, a state-of-the-art dental practice embracing groundbreaking technological innovations and techniques to treat and manage oral care, is now the first dental practice in the Western U.S. to utilize the first-ever medical grade 3D printer for dentistry.

Dee for Dentist, a state-of-the-art dental practice embracing groundbreaking technological innovations and techniques to treat and manage oral care, is now the first dental practice in the Western U.S. to utilize the first-ever medical grade 3D printer for dentistry – the Primeprint 3D Printing System by Dentsply Sirona. The highly automated advanced technology provides expanded treatment with same-day, in-house production as the printer can create temporary teeth, dentures, night guards, digital wax-ups, custom trays for impressions, surgical guides, and print dental models.

The FDA approved printer designed specifically for the dental industry is a highly automated, end-to-end, medical grade 3D printing system that helps to reduce handling times and enable a high level of productivity. Dee for Dentist acquired the technology in July.

“I founded Dee for Dentist with the goal of providing Southern Nevada access to the latest technology. To have a chairside 3D printer that can create teeth and dentures, among other things, in one day is an amazing service we are now able to offer. It is like science fiction has come to life, allowing us to take our level of patient care to the next level,” said Dr. Dee Dee Meevasin, owner and primary clinician at Dee for Dentist. “We can’t wait for our patients to witness the future of dental medicine right now – in the present.”

Prior to the release of the Primeprint system, chairside 3D printing was messy, inefficient, and unpredictable. Traditionally, a dental practice takes a patient scan, sends it to an outside lab to convert into a file that they can then print, or the lab manufactures the product and ships it back. With this new technology, the entire process is automated in-house, significantly reducing human error by eliminating the need for employees to wear gloves, rinse equipment and manually process the materials. The all-digital system also improves accuracy, treatment outcomes, and workflow efficiencies while eliminating wasted materials and decreasing time spent on technician training.

Founded in 2011, Dee for Dentist is a family practice providing state-of-the-art digital dentistry along with traditional dental services as a means to promote the long-term oral health of every patient. Dee for Dentist is open Monday through Saturday from 9 a.m. to 5:30 p.m. and is located at 8772 S Maryland Pkwy, Las Vegas, NV 89123. For more information, visit http://www.deefordentist.com.

About Dee for Dentist:

An industry leader introducing new dental technology to the Las Vegas community, Dee for Dentist is a family practice providing state-of-the-art digital dentistry. Dr. Dee Dee Meevasin, a Las Vegas native and a graduate of the UNLV School of Dental Medicine with over two decades of industry experience, started the practice in 2011 and embraces technology along with traditional dental services as a means to promote the long-term oral health of every patient.

As the first in Las Vegas to use many of the groundbreaking innovations and techniques developed for the dental industry to treat and manage oral care, the practice offers the most advanced treatments available, including: laser dentistry, myofunctional therapy appliances for children, digital nitrous, oral sleep appliances, oral cancer detection, 3D printing, CEREC same-day crown restorations, and 3D screening for advanced airway analysis to address sleep apnea and other oral health related issues.

Dee for Dentist is a clinical partner for TeamSmile, a national organization that partners dental practices with professional athletic organizations to provide life-changing dental care to underserved children in local communities.

Dee for Dentist is open Monday through Saturday from 9 a.m. to 5:30 p.m. For more information, visit http://www.deefordentist.com or follow @deefordentist on Facebook and Instagram. Appointments can be requested online or made by calling (702) 586-7800.

Share article on social media or email:



Continued Growth Spurs USOSM’s Expansion of Chief Clinical Officer Role


USOSM President and CEO Richard Hall says Dr. Perciaccante and Dr. Bell are “a natural fit for this important role.”

Having two industry leaders in this position will enable us to focus more in two key areas: surgeon recruitment and clinical guidance.

In response to its continued growth, U.S. Oral Surgery Management (USOSM) – a specialty management services company that exclusively serves premier oral and maxillofacial surgeons – has decided to expand the scope of the chief clinical officer role, inviting Vincent J. Perciaccante, DDS, FACS, to join Colin S. Bell, DDS, MSD, as chief clinical officer.

“In the past, we’ve had one leader take on all of the responsibilities of this role, but we’ve grown tremendously and in order to continue our momentum, we feel it’s the right time to expand that role to include a second chief clinical officer. Having two industry leaders in this position will enable us to focus more in two key areas: surgeon recruitment and clinical guidance,” said Richard Hall, USOSM president and CEO. “Dr. Bell and Dr. Perciaccante are a natural fit for this important role. Both have served as president of the American Board of Oral and Maxillofacial Surgery (ABOMS), which is the certifying board for our industry, here in the U.S. Both doctors are natural networkers and are known throughout the industry for their experience and expertise.”

In his new role, Dr. Bell will be responsible for new associate development and surgeon recruitment. Dr. Bell is a member of the USOSM Clinical Governance Board, which advises USOSM and its partner practices on important clinical issues oral and maxillofacial surgeons encounter. In addition, Dr. Bell is a founding partner and retired surgeon of Oral Surgery Associates of North Texas, a USOSM partner practice with five locations in the Dallas-Fort Worth Metroplex.

He is a fellow of both the American and the International College of Dentists and a member of the American Dental Association (ADA) and the OMS National Insurance Company Board of Directors. He is a past president of ABOMS, the Texas Society of Oral and Maxillofacial Surgeons and the Southwest Society of Oral and Maxillofacial Surgeons. In addition, he is a clinical professor of oral and maxillofacial surgery at Texas A&M College of Dentistry and is a member of the American Association of Oral and Maxillofacial Surgeons (AAOMS), where he serves in the House of Delegates.

“I was one of the first surgeon partners to join USOSM and it has been a great experience for me. That’s why I do what I do now,” notes Dr. Bell. “The USOSM business model works exceptionally well, but it only works, if we continue to attract excellent practitioners. That’s why recruitment is so important. We focus on getting new practices to join, as well as recruiting young associates who are just beginning their careers and are looking for a better way to be in private practice. There’re only a little over 200 graduates per year, so it’s very competitive, but USOSM has several big advantages we can offer them financially, and as equity partners, among other things.”

In his new role, Dr. Perciaccante will be responsible for business development, clinical compliance and clinical processes, ensuring all USOSM partner practices have access to best practices and clinical guidance. Dr. Perciaccante is a managing partner of and practicing surgeon with South Oral & Maxillofacial Surgery, a USOSM partner practice with three locations in the Atlanta, Georgia, area. He has served as president of ABOMS, the Georgia Society of Oral & Maxillofacial Surgeons and the Oral & Maxillofacial Surgery section of the International Association of Dental Research.

Dr. Perciaccante is a diplomate of both the ABOMS and the National Dental Board of Anesthesiology, as well as a fellow of AAOMS and the American College of Surgeons. He is a member of the USOSM Clinical Governance Board, the ADA, the Georgia Dental Association and the Northern District Dental Society. He also is a consultant to the Georgia Board of Dentistry on Anesthesia and a site visitor for the ADA’s Commission on Dental Accreditation, examining OMS resident training programs.

“One of my main duties is to be a liaison between USOSM’s surgeon partners and management, and I have a lot of experience with shared governance. I’ve been a part of both worlds and am able to walk the line between them well,” said Dr. Perciaccante. “I look forward to the making a difference in this new role.”

Headquartered in Irving, Texas, USOSM has partner practices spanning 19 states. They include Texas, Colorado, Georgia, Tennessee, Minnesota, Alabama, Oklahoma, Louisiana, South Carolina, Mississippi, Florida, Indiana, Kentucky, Arizona, California, Oregon, Virginia, Washington and Massachusetts. A shared services organization, USOSM collaborates with premier oral and maxillofacial surgeons to offer a partnership solution for continued and accelerated practice success. USOSM provides operational, marketing and administrative support services, reinvests resources, and applies best practices to improve clinical and financial performance and produce steadier, more profitable growth for all. For more information, visit https://www.usosm.com/.

Share article on social media or email:

Smaller Lung Airways May Increase COPD Risk in Women


The differences in airway dimensions even after adjusting for height and lung size, and the greater impact of changes in airway size on clinical outcomes in women, was remarkable in that women appear to have a lower reserve against developing airway disease and COPD.

Structural differences in lung airways between men and woman may be the cause of differences in chronic obstructive pulmonary disease (COPD) prevalence and outcomes between the sexes. According to a large, multicenter study published in the journal Radiology, researchers found that even among adults who have never smoked, or who have smoked less than 100 cigarettes in their lifetime, lung airways were smaller in women, which can lead to a higher risk for lung disease.

COPD refers to a group of diseases, such as emphysema and chronic bronchitis, that cause airflow blockage and breathing-related problems. More than 15 million Americans have COPD, according to the Centers for Disease Control and Prevention.

Overall, men have a higher rate of diagnosis and mortality, but with changes in smoking behavior and increasing urbanization, the prevalence of COPD in women is on the rise.

“The prevalence of COPD in women is fast approaching that seen in men, and airway disease may underlie some of the high COPD numbers in women that we are seeing,” said the study’s lead author, Surya P. Bhatt, M.D., M.S.P.H., associate professor of medicine, Division of Pulmonary, Allergy and Critical Care Medicine at the University of Alabama at Birmingham. “When airways narrow due to cigarette smoking, the impact on symptoms and survival is greater in women than in men.”

The assumption that women have smaller airways is based on comparisons of the trachea and main stem bronchi, but few studies have compared distal airways in normal individuals or accounted for differences in lung size.

For this study, researchers analyzed data from nearly 10,000 participants enrolled in Genetic Epidemiology of COPD (COPDGene), a prospective multicenter observational cohort study of current and former smokers, as well as never smokers, between the ages of 45 and 80 years, at 21 clinical centers across the United States. The researchers looked at data of never, current and former smokers enrolled in COPDGene from January 2008 to June 2011 and followed up longitudinally until November 2020.

Airway disease on CT was quantified using seven metrics: airway wall thickness, wall area percent, Pi10 (square root of the wall thickness of a hypothetical airway with internal perimeter of 10 mm) for airway wall, lumen (airway passage in which air flows through) diameter, airway volume, total airway count and airway fractal dimension for airway lumen.

Each airway metric was calculated and adjusted for age, height, race, body mass index, pack-years of smoking, current smoking status and total lung capacity.

“The growth of airways and lungs in early life is generally more proportionate in women than in men,” Dr. Bhatt said.

In 420 never-smokers, CT scans revealed that men had thicker airway walls than women, whereas, after accounting for height and total lung capacity, airway lumen dimensions were lower in women than in men.

In 9,363 current and former smokers, men had greater wall thickness, whereas women had narrower segmental lumen diameter. A unit change in each of the airway metrics (higher wall or lower lumen measure) resulted in lower lung function, more dyspnea (shortness of breath), poorer respiratory-quality of life, lower six-minute walk distance and worse survival in women compared with men.

“The differences in airway dimensions even after adjusting for height and lung size, and the greater impact of changes in airway size on clinical outcomes in women, was remarkable in that women appear to have a lower reserve against developing airway disease and COPD,” Dr. Bhatt noted.

Dr. Bhatt noted that the research implicates that sex differences should be factored into the development of new therapies for airway disease.

###

“Sex Differences in Airways at Chest CT: Results from the COPDGene Cohort.” Collaborating with Dr. Bhatt were Sandeep Bodduluri, Ph.D., Arie Nakhmani, Ph.D., Young-il Kim, Ph.D., Joseph M. Reinhardt, Ph.D., Eric A. Hoffman, Ph.D., Amin Motahari, Ph.D., Carla G. Wilson, M.S., Stephen M. Humphries, Ph.D., Elizabeth A. Regan, M.D., and Dawn L. DeMeo, M.D., M.P.H.

Radiology is edited by David A. Bluemke, M.D., Ph.D., University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, and owned and published by the Radiological Society of North America, Inc. (https://pubs.rsna.org/journal/radiology)

RSNA is an association of radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Illinois. (RSNA.org)

For patient-friendly information on chest CT, visit RadiologyInfo.org.

Kvarøy Arctic Partners with Whole Kids Foundation to Improve Children’s Nutrition


News Image

Quality of life for the world’s children in 2050 depends on our decisions today. Every decision we make must stem from a deeply rooted commitment to protecting the planet for future generations.

Kvarøy Arctic (pronounced “Kwa-ray”) joins forces with Whole Kids Foundation, a nonprofit established by Whole Foods Market, as their official sponsor and supporter in their mission to improve children’s nutrition in the US. The Norway-based, sustainable salmon farm has pledged a $10,000 annual contribution for 2022, with plans on expanding the program in 2023.

The collaboration is based on creating educational content that sparks curiosity among children to learn about sustainable and nutritious food systems. This partnership will develop and provide engaging resources for teachers, parents, students, and school communities as both organizations share the vision that children’s education on healthy eating and climate-friendly food systems go hand in hand. With a focus on healthy eating, the environment, and sustainability, Kvarøy Arctic and Whole Kids Foundation can help kids eat better while enjoying it!

Kvarøy Arctic’s CEO, Alf-Goran Knutsen says: “Quality of life for the world’s children in 2050 depends on our decisions today. Every decision we make must stem from a deeply rooted commitment to protecting the planet for future generations. There’s an old saying, ‘We do not inherit the world from our parents. We borrow it from our children.’ This is the tenet from which all of our actions are based. Kvarøy Arctic has been committed to being a part of a contributive and sustainable food system since 1976.”

“An important part of Whole Kids Foundation’s mission has always been about inspiring families. Our partnership with Kvarøy will allow us to broaden our educational support for teachers and families everywhere and help them discover small healthy eating changes that can make a big difference in their nutrition and wellness,” said Nona Evans, Executive Director of Whole Kids Foundation. “The team at Kvarøy truly understands that our kids have an enormous capacity to understand where food comes from and the impact it has on our bodies and environments. Together we hope to fuel the next generation of healthy leaders!”

About Kvarøy Arctic:

Kvarøy Arctic is a third-generation Atlantic salmon farm on the Island of Kvarøy along Norway’s Arctic Circle. Led by CEO Alf-Gøran Knutsen, Production Manager Gjermund Olsen, and Operations Manager Håvard Olsen, the Kvarøy Arctic team is ushering in a new era of sustainability for salmon farming as a net producer of fish protein with a commitment to traceability and transparency through IBM blockchain technology.

Recognized by FastCo as one of the World’s Most Innovative Companies in 2022, Kvarøy Arctic is the first farmed finfish to carry the Fair Trade USA seal, and is BAP, ASC and Global G.A.P. certified. The salmon has the merroir of Norway’s cold, clear waters with delicate marine flavors and slight brininess. It is one of a small number of farm-raised fish certified by the American Heart Association’s® Heart-Check program.

Kvarøy Arctic is currently available for direct delivery on Amazon.com, through Pod Foods, at restaurants, and at select retailers like Whole Foods Market U.S. locations, Giant Eagle stores, and more.

Whole Kids Foundation supports schools and inspires families to improve children’s nutrition and wellness. Founded by Whole Foods Market in 2011, the independent, nonprofit organization is based in Austin, Texas and serves schools and organizations in the US, Canada, and the UK. For more information on the Foundation’s school programs including school gardens, salad bars, beehives, and nutrition education for teachers, visit wholekidsfoundation.org.

Share article on social media or email:

OCLI Vision Welcomes Optometrist, Dr. Lily Chin, to the Team


Tom Burke, Spectrum Vision Partners’ CEO gave a warm welcome to Dr. Chin. “Welcome to the team, Dr. Chin. Given your impressive resume, we know you’ll be a great addition to OCLI Vision.”

OCLI Vision welcomes talented Lily Chin, OD, to the growing team of eye care professionals providing advanced eye care to the Northeast. Dr. Chin is a graduate of the SUNY College of Optometry and New York University.

Dr. Chin has extensive experience and training in ocular pathology management of glaucoma, cataracts, and corneal and retinal disease. Dr. Chin provides comprehensive eye exams including spectacle and contact lens fittings for spherical, toric, and presbyopia. Additionally, Dr Chin can diagnose, treat, and manage patients with dry eyes, corneal, uveitis, diabetic retinopathy, glaucoma, and macular degeneration.

“I’m grateful to be joining the world-class team at OCLI Vision,” stated Dr. Chin. “It’s always encouraging to be surrounded by colleagues that I can learn from and support. My hope is to give my patients access to advanced eye care services and technology, ensuring they get the treatment and attention they need to achieve their eye care goals.”

OCLI Vision is a leading ophthalmology practice whose growth is supported by the management and administrative services of Spectrum Vision Partners (SVP), an organization serving many of the top ophthalmology groups and ambulatory eye surgery centers in New York, New Jersey, Connecticut, Pennsylvania, and West Virginia. Dr. Chin will be seeing patients at multiple locations on Long Island.

Tom Burke, Spectrum Vision Partners’ CEO gave a warm welcome to Dr. Chin. “Welcome to the team, Dr. Chin. Given your impressive resume, we know you’ll be a great addition to OCLI Vision.”

For more information about OCLI Vision and Spectrum Vision Partners, please contact:

Greg Wappett

Chief Development Officer

gwappett@spectrumvisionpartners.com

Tom Burke                                                    

Chief Executive Officer                                                                    

tburke@spectrumvisionpartners.com

About OCLI Vision

Founded in 1997, OCLI Vision (https://www.ocli.net) is one of the leading ophthalmology and optometry practices in the United States. The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania, and West Virginia. OCLI Vision is led by a large group of highly skilled ophthalmologists and optometrists in each major sub-specialty of eye care, who provide comprehensive eye care services, including treatment for cataracts, corneal disease, glaucoma, retinal disease, oculoplastics, refractive surgery, and neuro-ophthalmology.

About Spectrum Vision Partners

Spectrum Vision Partners (SVP) (http://www.spectrumvisionpartners.com) is a leading management services organization, serving the ophthalmology sector. With nearly 1,300 employees providing world-class practice management and administrative solutions to a network of nationally renowned, multi-specialty ophthalmologists in New York, New Jersey, Connecticut, Pennsylvania and West Virginia, SVP supports over 40 clinic locations, five state-licensed ambulatory surgery centers, and over 110 surgeons, doctors and other medical professionals. SVP provides a comprehensive set of business support functions, including billing and collections, credential services, marketing, physician recruitment, ASC development, financial and accounting services, benefits and payroll management and information technology. The company’s corporate service center is located at 825 East Gate Boulevard, Suite 111, Garden City, NY 11530.

Share article on social media or email:

MedMatch Network Names Joseph L. Ortiz Chief Innovation and Operations Officer


“Joe comes to MedMatch Network with extensive expertise and experience in the healthcare industry across healthcare technology, digital systems, software IP and entrepreneurship, and clinical practice IT and operations,” said MedMatch Founder and CEO Amos Daré, MD, FACS.

MedMatch Network, an innovative healthcare information technology firm focused on facilitating patient referral management and information exchange for seamless continuity of care, appoints Joseph L. Ortiz, MSCE, MBA, PMP, ITIL 4.0 as Chief Innovation and Operations Officer for the company. The company is poised to grow aggressively nationwide with its cloud-based platform of medical providers facilitating reliable, automated patient referral management and secure information exchange.

“Joe comes to MedMatch Network with extensive expertise and experience in the healthcare industry across healthcare technology, digital systems, software IP and entrepreneurship, and clinical practice IT and operations,” said MedMatch Founder and CEO Amos Daré, MD, FACS. “We are poised for significant growth and utilization in our provider referral platform across the U.S. Joe’s experience in digital technology-based business, from IP development to engineering, to marketing, sales, and operations, is a perfect fit for helping us organize and grow to the next level and beyond.”

Ortiz brings over 30 years of digital technology business experience to his role at MedMatch Network. In his most recent executive position, he was the first Chief Information Officer for Summit Medical Group. In this role, Ortiz was responsible for the IT operations of a 225+ provider group covering 65+ sites in 13 counties and developing a healthcare technology platform strategy to support the group’s spinout business, Summit Strategic Solutions. Before this, Ortiz launched 4D Imaging Systems, which focused on healthcare visual data capture and analysis of change over time. He has held various management roles for startups and multi-national firms, including Motorola, Phillips Consumer Electronics, IPIX Corporation, RDI Technologies, and NCR.

“I am incredibly excited to be working with Dr. Daré and the MedMatch Network team, helping create a world in which medical practitioners and patients communicate and exchange health information easily and securely to improve healthcare delivery,” Ortiz said. “Dr. Daré has done a fantastic job of positioning MedMatch Network to structurally redefine how a patient’s care journey transitions from one provider to another. In joining with him to grow the company, codify our IP, and provide a fantastic journey for our customers, I know we are well-poised to make a significant difference in our existing healthcare system.”

About MedMatch Network

MedMatch Network is an innovative, disruptive healthcare information technology firm that offers an integrated ‘B2B2C’ platform that helps healthcare providers manage their patient referrals and exchange patient records while providing patients with convenient access to their providers and their medical information. MedMatch Network provides interoperability, connecting all providers on the same platform to improve the patient journey through the healthcare system.

MedMatch Network. Follow us on LinkedIn.

Media Questions?

Please email info@medmatchnetwork.com

Share article on social media or email:

Alley Cat Rescue Disputes Polish Academy of Science Classification of Cats as ‘Invasive Alien Species’


Photo by Krzysztof Niewolny on Unsplash

Given the deadly persecution that cats face in places such as Australia…Hawaii in the name of environmental protection, attaching such stigmatic terminology to cats in Europe could give rise to culls there as well.

The government-funded Polish Academy of Sciences has classified domestic cats (Felis catus) as an “invasive alien species.” This designation is given to species that are not native to a region’s ecosystem, and cause damage to that ecosystem. The institute has said that the label is purely scientific and not a call to action against cats. They say that the number of birds and other small native animals cats kill per year qualifies them to be on the listed this way in their national database.

Alley Cat Rescue (ACR) criticized the Academy’s decision in a blog post on their website:

“Given the deadly persecution that cats face in places such as Australia and, sadly, Alaska and Hawaii in the name of environmental protection, attaching such stigmatic terminology to cats in Europe could give rise to culls there as well.

Beyond the Academy’s moral responsibility to avoid putting cats’ lives in danger, the classification is based on shaky science. There simply is not sufficient information available to determine if cat predation has any detrimental effects on the overall populations of prey animals, including birds; yet environmental and bird groups, like the American Bird Conservancy, continue to push for the eradication of feral cats, claiming cats are in fact contributing to the decline of bird species and other wildlife. The few studies that have been conducted on cat predation are from remote islands with closed ecosystems, where local bird popula­tions have not evolved with predators. Because cat predation on continents is very different from island environments, it is inaccurate and inappro­priate to extrapolate data from these particular studies to predict predation on continents.”

ACR also argues that, like any predator, cats tend to feed on the young or old and those who are sick or in a weakened state because they are the easiest to catch, citing the UK’s Royal Society for the Protection of Birds (RSPB), which states, “It is likely that most of the birds killed by cats would have died anyway from other causes before the next breeding season, so cats are unlikely to have a major impact on populations. Every year, many millions of birds die naturally due to starvation, disease, or other forms of predation. And most of the millions of baby birds hatched each year will die before they reach breeding age,” (RSPB, 2014).

In the blog article, Alley Cat Rescue offers the opinion that cats are easy scapegoats for governments and institutions so they can avoid addressing much larger environmental hazards. ACR points to the European Environment Agency (EEA)’s webpage that claims agriculture is the primary danger to nature in Europe. The site also names habitat loss and damage, unsustainable forestry, hunting, and overfishing as greater threats to wildlife than “alien invasive species.”

Alley Cat Rescue concludes that it is unwise for a reputable institution to officially label cats as a danger to the natural environment in Europe as it accomplishes nothing has but to spark or fuel animosity toward cats. They stress that instead of blaming cats, the best thing communities around the world can do is practice trap-neuter-return (TNR) to end outdoor cat overpopulation. Thousands of nonprofit groups Alley Cat Rescue have TNR programs that benefit wildlife without harming cats.

Share article on social media or email: